Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics
作者： T. C. Pomfret , J. M. Gagnon Jr , A. T. Gilchrist
DOI: 10.1111/J.1365-2710.2009.01150.X
关键词:
摘要: … response after quadrivalent HPV vaccine administration in sexually active 11- to 15-year-old boys… in a trial of women 18–45 years of age to evaluate the impact of therapy on neutralizing …
sci-hub.se 参考文章(19)
Suresh Hedau, V. Gopalkrishna, Sanjay Katiyar, B. C. Das, Cancer of the uterine cervix and human papillomavirus infection Current Science Association. ,(2000)
C E Greer, C M Wheeler, M B Ladner, K Beutner, M Y Coyne, H Liang, A Langenberg, T S Yen, R Ralston, Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. Journal of clinical microbiology. ,vol. 33, pp. 2058- 2063 ,(1995) , 10.1128/JCM.33.8.2058-2063.1995
F. X. Bosch, S. de Sanjose, Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality. Journal of The National Cancer Institute Monographs. ,vol. 2003, pp. 3- 13 ,(2003) , 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003479
Randall Fisher, David H Darrow, Margene Tranter, Judith V Williams, Human papillomavirus vaccine: recommendations, issues and controversies. Current Opinion in Pediatrics. ,vol. 20, pp. 441- 445 ,(2008) , 10.1097/MOP.0B013E328305E298
Eliav Barr, Christine K. Gause, Oliver M. Bautista, Radha A. Railkar, Lisa C. Lupinacci, Ralph P. Insinga, Heather L. Sings, Richard M. Haupt, Impact of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine in a sexually active population of North American women. American Journal of Obstetrics and Gynecology. ,vol. 198, pp. 261- 263 ,(2008) , 10.1016/J.AJOG.2007.09.001
Hillard Weinstock, Stuart Berman, Willard Cates, Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspectives on Sexual and Reproductive Health. ,vol. 36, pp. 6- 10 ,(2004) , 10.1363/3600604
Anna R. Giuliano, Human papillomavirus vaccination in males. Gynecologic Oncology. ,vol. 107, ,(2007) , 10.1016/J.YGYNO.2007.07.075
Keith S. Reisinger, Stan L. Block, Eduardo Lazcano-Ponce, Rudiwilai Samakoses, Mark T. Esser, Joanne Erick, Derek Puchalski, Katherine E. D. Giacoletti, Heather L. Sings, Suzanne Lukac, Frances B. Alvarez, Eliav Barr, Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial. Pediatric Infectious Disease Journal. ,vol. 26, pp. 201- 209 ,(2007) , 10.1097/01.INF.0000253970.29190.5A
Anna Pallecaros, Barbara Vonau, Human papilloma virus vaccine – more than a vaccine Current Opinion in Obstetrics and Gynecology. ,vol. 19, pp. 541- 546 ,(2007) , 10.1097/GCO.0B013E3282F1A91B
Anna R Giuliano, Eduardo Lazcano-Ponce, Luisa Villa, Terry Nolan, Colin Marchant, David Radley, Greg Golm, Kathleen McCarroll, Jimmy Yu, Mark T Esser, Scott C Vuocolo, Eliav Barr, None, Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine. The Journal of Infectious Diseases. ,vol. 196, pp. 1153- 1162 ,(2007) , 10.1086/521679